AptarGroup, Inc. with ticker code (ATR) now have 4 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 150 and 125 and has a mean target at $136.75. Now with the previous closing price of $122.09 this now indicates there is a potential upside of 12.0%. Also worth taking note is the 50 day moving average now sits at $117.77 while the 200 day moving average is $113.83. The company has a market cap of 7.96B. The stock price is currently at: 121.54 USD
The potential market cap would be $8,919,687,431 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 34.93, revenue per share of 51.83 and a 5.73% return on assets.
AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma includes operations that sells dispensing systems and sealing solutions and also manufactures and sells elastomeric primary packaging components. The Company’s products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. This segment offers food protection business and elastomeric flow-control technology business.
